Cargando…
CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
BACKGROUND: Tetraspanins CD151, a transmembrane 4 superfamily protein, has been identified participating in the initiation of a variety of cancers. However, the precise function of CD151 in non-small cell lung cancer (NSCLC) remains unclear. Here, we addressed the pro-tumoral role of CD151 in NSCLC...
Autores principales: | Zhu, Jianjie, Cai, Tingting, Zhou, Jieqi, Du, Wenwen, Zeng, Yuanyuan, Liu, Ting, Fu, Yulong, Li, Yue, Qian, Qian, Yang, Xiuwei H., Li, Qinglin, Huang, Jian-an, Liu, Zeyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191020/ https://www.ncbi.nlm.nih.gov/pubmed/34108040 http://dx.doi.org/10.1186/s13046-021-01998-4 |
Ejemplares similares
-
CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion
por: Zhou, Pengcheng, et al.
Publicado: (2015) -
Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression
por: Zhou, Jieqi, et al.
Publicado: (2022) -
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
por: Fu, Yulong, et al.
Publicado: (2020) -
An extracellular site on tetraspanin CD151 determines α3 and α6 integrin–dependent cellular morphology
por: Kazarov, Alexander R., et al.
Publicado: (2002) -
Anlotinib can overcome acquired resistance to EGFR‐TKIs via FGFR1 signaling in non‐small cell lung cancer without harboring EGFR T790M mutation
por: Lian, Zengzhi, et al.
Publicado: (2020)